| ¿µ¹® | mortality | ÇÑ±Û | »ç¸Á·ü |
|---|---|---|---|
| ¼³¸í | ¾î´À Àα¸Áý´ÜÀ» ´ë»óÀ¸·Î ÇÑ 1³â°£ÀÇ »ç¸ÁÀÚ¼ö°¡ ±× ÇØÀÇ ±× Àα¸Áý´Ü Àüü Àα¸¿¡ ´ëÇÏ¿© Â÷ÁöÇÏ´Â ºñÀ². º¸Åë Àα¸ 1,000¸í¿¡ ´ëÇÑ ¼ýÀÚ·Î ³ªÅ¸³½´Ù. ±×·¯³ª ¿øÀκ° »ç¸Á·üÀº ÆíÀÇ»ó Àα¸ 10¸¸¸íÀ» ´ë»óÀ¸·Î ³ªÅ¸³½´Ù. »ç¸Á·üÀº ¿¬Â÷-Áö¿ª-Á÷¾÷-¼ºº° µî¿¡ µû¶ó ´Ù¸£±â ¶§¹®¿¡, ¾î´À Áý´ÜÀ» ´Ù¸¥ Áý´Ü°ú »ç¸ÁÀÇ ºóµµ¸¦ ºñ±³ÇÒ ¶§´Â Á¶Á¤»ç¸Á·ü(adjusted death rate)À» »ç¿ëÇÑ´Ù. Áï ÇÑ Áý´ÜÀÇ ¿¬·Éº° »ç¸Á·üÀ» ±¸ÇÑ µÚ¿¡ ÀÏÁ¤ÇÑ ¿¬·É±¸¼ºÀ» °¡Áø Ç¥ÁØÀα¸ÀÇ »ç¸Á·ü°ú ºñ±³ÇÏ´Â °ÍÀÌ´Ù. À̸¦ Á¶Á¤»ç¸Á·üÀ̶ó Çϸç, óÀ½¿¡ ¸»ÇÑ »ç¸Á·üÀº À̰Ͱú ´ëºñÇÑ´Ù´Â ¶æ¿¡¼ Á¶»ç¸Á·üÀ̶ó ÇÑ´Ù. |
||
| ¿µ¹® | morbidity | ÇÑ±Û | ÀÌȯ·ü |
|---|---|---|---|
| ¼³¸í | º´¿¡ °É¸®´Â Á¤µµ¸¦ Ç¥½ÃÇÏ´Â Åë°èÀû ÁöÇ¥. Áï, ¾î¶² °¨¿°¿¡ ´ëÇÑ Á¢ÃËÀ̳ª, ȤÀº ¹æ»ç¼± µî¿¡ Æø·ÎµÇ¾úÀ» ¶§, ¾î¶² º´À̳ª ¼Õ»óÀ» ÀÔ°Ô µÉ Á¤µµ¸¦ ¸»ÇÑ´Ù. ¾î¶² º´Àû»óŸ¦ °¡Áö°í ÀÖ´Â »óŸ¦ Åë°èÀû Àǹ̷Π¾µ¶§ »ç¿ëÇÑ´Ù. ÀÌ·± °³³äÀº ¿¹¸¦ µé¾î, Ä¡·á¹æ»ç¼±°ú¿¡¼´Â ÇʼöÀûÀÌ µÈ´Ù. ¿Ö³ÄÇÏ¸é ¾Ï¿¡ ´ëÇ×ÇØ ¾²´Â ¹æ»ç¼±Àº ´ç¿¬È÷ Á¤»óÀûÀÎ Á¶Á÷¿¡µµ ÇØ¸¦ ¹ÌÄ¥ °ÍÀ̹ǷÎ, ÀÌ Á¤»óÀûÀÎ Á¶Á÷¿¡ ¹ÌÄ¥ ÀÌȯ·üÀ» ÃÖ¼Ò·Î Çϰí, ¾ÏÀÇ Ä¡·á¸¦ ½ÃÇàÇØ¾ß Çϱ⠶§¹®ÀÌ´Ù. |
||
| ¿µ¹® | Dilatation and Curettage(D & C) | ÇÑ±Û | Àڱñܾ¼ú, ÀڱøñÈ®Àå |
|---|---|---|---|
| ¼³¸í | ÀÚ±ÃÀ̶õ žư¡ ¼öÅÂµÇ¾î¼ ºÐ¸¸Àü±îÁö ¹ßÀ°ÇÏ°í ¼ºÀåÇÏ´Â °ø°£ÀÌ´Ù. Àڱüӿ¡ º´º¯ÀÌ ÀÖ¾î ÀÓ½ÅÀÌ °è¼ÓµÉ ¼ö ¾ø°Å³ª ¾Æ´Ï¸é ´Ù¸¥ ÀÌÀ¯·Î ÀӽŵǾî Àִ žƸ¦ Á¦°ÅÇϰíÀÚ ÇÒ °æ¿ì¿¡ »ç¿ëµÇ´Â ¹æ¹ýÀÌ´Ù. ¿©±â¼ ±Ü¾î³»±â À§ÇÏ¿©´Â ¿ì¼± ÀÚ±ÃÀÇ ÀÔ±¸¿¡ ÇØ´çÇÏ´Â ÀڱøñÀ» È®Àå½ÃÄÑ¾ß ÇÑ´Ù. ¿©±â¿¡´Â ±Þ¼ÓÈ÷ È®ÀåÀ» ½ÃµµÇÏ´Â ¹ý°ú ¼¼È÷ È®ÀåÀ» ½ÃµµÇÏ´Â 2°¡Áö ¹æ¹ýÀÌ ÀÖ´Ù. ÀڱøñÀ» ±Þ¼ÓÈ÷ È®ÀåÇÒ ¶§´Â Çì°¡¸£ ¸ñ°üÈ®Àå±â(Hegar's dilatator)¸¦ »ç¿ëÇÑ´Ù. À̰ÍÀº ÀÛÀº ±Ý¼Ó¸·´ë·Î ÀÛÀº Å©±âºÎÅÍ Å« Å©±â±îÁö ´Ù¾çÇÑ Å©±â°¡ ÀÖ¾î¼ ¿ì¼± ÀÛÀº ¸·´ë·Î ½ÃÀÛÇÏ¿© Á¡Á¡ Å« Å©±âÀÇ ¸·´ë¸¦ Àڱøñ¿¡ ³Ö¾î¼ ÀڱøñÀ» È®Àå½ÃŲ´Ù. ¼¼È÷ È®Àå½Ãų ¶§´Â Laminaria tent¸¦ ¸ñ°ü¿¡ »ðÀÔÇÏ´Â ¹æ¹ýÀ» »ç¿ëÇÑ´Ù. Laminaria tent¶õ ÇØÃÊ·Î ¸¸µç ÀÛÀº ¸·´ë·Î ¼öºÐÀ» Èí¼öÇϸé Á¡Á¡ ´Ã¾î³ª´Â ¼ºÁúÀÌ ÀÖ´Ù. À̰ÍÀ» ÀÚ±ÃÀÇ ¸ñ¿¡ ³ÖÀ¸¸é À̰ÍÀÌ ¼öºÐÀ» Èí¼öÇÏ¿© ´Ã¾î³ª¹Ç·Î õõÈ÷ ÀÚ±ÃÀÇ ¸ñÀÌ ´Ã¾î³´Ù. ÀڱøñÀÌ ÃæºÐÈ÷ ´Ã¾î³ª¸é ±× ¼ÓÀ¸·Î ³¡ÀÌ ¼ù°¡¶ôó·³ »ý±ä ±â±¸¸¦ ³Ö¾î¼ ÀڱüÓÀÇ º´º¯À̳ª ÀÓ½ÅµÈ Å¾Ƹ¦ ±Ü¾î³»´Âµ¥ ¿©±â¿¡ »ç¿ëµÇ´Â ¼ù°¡¶ôó·³ »ý±ä ±â±¸¸¦ Å¥·¿À̶ó°í ÇÑ´Ù. Ãʱâ ÀÓ½ÅÁßÀý Áï À¯»ê°ú °°Àº ÀӽŰú °ü·ÃµÈ °æ¿ì»Ó¸¸ ¾Æ´Ï¶ó, ºñÀӽŠÀÚ±ÃÀÇ Àڱ󻸷Á¶Á÷ÀÇ Ã¤Ãë ¹× Á¦°Å¸¦ À§Çؼµµ ÇàÇØÁö´Â ¼ö±âÀÌ´Ù. ÀÌ´Â ¿øÄ¢ÀûÀ¸·Î ¸¶ÃëÇÏ¿¡ ½Ç½ÃµÇ´Â °ÍÀ¸·Î Àڱøñ°üÀ» È®ÀåÇÏ°í ±â±¸·Î Àڱà ³»¿ë¹°À» Á¦°ÅÇϰí Å¥·¿À¸·Î Àڱ󻺮À» ±ú²ýÀÌ ÇÑ´Ù. ÀÚ±Ãõ°øÀ̳ª ÀڱøñÀÇ ÆÄ¿ µîÀÇ À§ÇèÀÌ µû¸£¸ç, ¼ö¼úÈÄ °¨¿° ¶Ç´Â ÃâÇ÷ µî¿¡ ´ëÇÑ ÁÖÀǰ¡ ÇÊ¿äÇÏ´Ù. |
||
| MMWR | Morbidity and Mortality Weekly Report |
|---|---|
| PMR | patient meta-record; perinatal mortality rate; periodic medical review; physical medicine and rehabi... |
| MM | macromolecule; Maelzels metronome; major medical [insurance]; malignant melanoma; manubrium to malle... |
| M&M | morbidity and mortality |
| MR | Maddox rods; magnetic resistance; magnetic resonance; mandibular reflex; mannose-resistant; may repe... |
| PTWI | Provisional Tolerable Weekly Intake |
|---|---|
| TIW | times weekly |
| MPM | Minor Psychiatric Morbidity |
| NCS | National Co-morbidity Survey |
| SAS-SR | Social Adjustment Scale Self-Report |
CDC
| weekly | 1. Of or pertaining to a week, or week days; as, weekly labour. 2. Coming, happening, or done once a week; hebdomadary; as, a weekly payment; a weekly gazette. Once a week; by hebdomadal periods; as, each performs service weekly. Source: Websters Dictionary (01 Mar 1998) |
|---|---|
| cancer, colon: screening and surveillance | Colon cancer is both preventable and curable. It is preventable by removing precancerous colon polyps. It is curable if early cancer is surgically removed before cancer spread to other parts of the body. Therefore, if screening and surveillance programs were practiced universally, there would be a major reduction in the incidence and mortality of colon cancer. (12 Dec 1998) |
| meeting report | A published record of the presentations at a meeting of a society, association, or similar body or of transactions at a symposium, colloquium, seminar, workshop, round table, conference, or congress. Mere notification of the date and place of the meeting is not within the scope of this publication type. It is to be used, rather, for the proceedings or transactions of the sessions, often with presentation of papers. (12 Dec 1998) |
| technical report | A formal report giving details of the investigation and results of a medical or other scientific problem. When issued by a government agency or comparable official body, its contents may be classified, unclassified, or declassified with regard to security clearance. This publication type may also cover a scientific paper or article that records the current state or current position of scientific research and development. If so labelled by the editor or publisher, this publication type may be properly used for journal articles. (12 Dec 1998) |
| genes, cdc | Genes that code for proteins that regulate the cell division cycle. These genes form a regulatory network that culminates in the onset of mitosis by activating the p34cdc2 protein (protein p34cdc2). (12 Dec 1998) |
| CDC | The Centres for Disease Control and Prevention (CDC). The American agency charged with tracking and investigating public health trends. Its stated mission is To promote health and quality of life by preventing and controlling disease, injury, and disability. A part of the U.S. Public Health Services (PHS) under the Department of Health and Human Services (HHS), the CDC is based in Atlanta, Georgia. It publishes key health information including weekly data on all deaths and diseases reported in the United States ( Morbidity and Mortality Weekly Report ) and travelers' health advisories. (12 Dec 1998) |
| cdc gene | <molecular biology> Cell division cycle genes, of which many have now been defined, especially in yeasts. See cyclin. (18 Nov 1997) |
| morbidity | A diseased condition or state, the incidence of a disease or of all diseases in a population. (18 Nov 1997) |
| morbidity rate | The sickness rate, the number of people who are sick or have a disease compared with the number who are well. (09 Oct 1997) |
| puerperal morbidity | Illness arising during the first 10 days of the postpartum period, i.e., a temperature of 38°C (100.4°F) or more on any two days of the first 10, excluding the first 24 hours. (05 Mar 2000) |
| population surveillance | <epidemiology> Ongoing scrutiny of a population (general population, study population, target population, etc.), generally using methods distinguished by their practicability, uniformity, and frequently their rapidity, rather than by complete accuracy. (12 Dec 1998) |
| post-marketing surveillance | Procedure implemented after a drug has been licensed for public use, designed to provide information on use and on occurrence of side effects, adverse effects, etc. (05 Mar 2000) |
| product surveillance, postmarketing | Surveillance of drugs, devices, appliances, etc., for efficacy or adverse effects, after they have been released for general sale. (12 Dec 1998) |
| sentinel surveillance | Monitoring of rate of occurrence of specific conditions to assess the stability or change in health levels of a population. It is also the study of disease rates in a specific cohort, geographic area, population subgroup, etc. To estimate trends in larger population. (12 Dec 1998) |
| surveillance | Oversight; watch; inspection; supervision. "That sort of surveillance of which . . . The young have accused the old." (Sir W. Scott) Origin: F, fr. Surveiller to watch over; sur over + veiller to watch, L. Vigilare. See Sur-, and Vigil. Source: Websters Dictionary (01 Mar 1998) |
Á¦Ç°¸í |
ÆÇ¸Å»ç |
º¸ÇèÄÚµå | ¼ººÐ/ÇÔ·® | ±¸ºÐ/º¸Çè±Þ¿© |
|---|
Á¦Ç°¸í |
ÆÇ¸Å»ç |
º¸ÇèÄÚµå | ¼ººÐ/ÇÔ·® | ±¸ºÐ/º¸Çè±Þ¿© |
|---|